VJNeurology is committed to improving our service to you

Share this video  

VJNeurology is committed to improving our service to you

MDS 2020 | The future of tau therapies for movement disorders

Adam Boxer, MD, PhD, UCSF Weill Institute for Neurosciences, San Francisco, CA, discusses the future of discovering a successful tau therapy for movement disorders such as progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD). Prof. Boxer shows confidence in anti-tau therapies from genetic data and believes each trial failure progresses the search for a successful candidate. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).